Deutsch English Français

Contact

EP1901749

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1901749

EP1901749 - AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 09.06.2017 Database last updated on 14.06.2024
Most recent event Tooltip	09.06.2017	No opposition filed within time limit	published on 12.07.2017 [2017/28]
Applicant(s)	For all designated states Horizon Orphan LLC 150 South Saunders Road Lake Forest, IL 60045 / US
	[2017/08]
Former [2016/10]	For all designated states Raptor Pharmaceuticals Inc. 7 Hamilton Landing Suite 100 Novato, CA 94949 / US
Former [2008/13]	For all designated states MPEX PHARMACEUTICALS, INC. 3030 Bunker Hill Street, Suite 200 San Diego, CA 92109 / US
Inventor(s)	01 / SURBER, Mark, W. 4746 Edison Street San Diego, California 92117 / US
	02 / BOSTIAN, Keith, A. 6 Callado Way Atherton, California 94027 / US
	03 / LOMOVSKAYA, Olga 46 Laverne Avenue Mill Valley, California 94941 / US
	04 / GRIFFITH, David, C. 714 Bandak Court San Marcos, California 92069 / US
	05 / DUDLEY, Michael, N. 17257 Silver Gum Way San Diego, California 92127 / US
	[2008/13]
Representative(s)	Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[N/P]
Former [2016/31]	Nelson, Michael Andrew HGF Limited 1 City Walk Leeds LS11 9DX / GB
Former [2013/22]	polypatent BGL Braunsberger Feld 29 51429 Bergisch Gladbach / DE
Former [2008/13]	Polypatent Braunsberger Feld 29 51429 Bergisch Gladbach / DE
Application number, filing date	06760146.8	18.05.2006
	[2008/13]
	WO2006US19351
Priority number, date	US20050682530P	18.05.2005 Original published format: US 682530 P
	US20050696160P	01.07.2005 Original published format: US 696160 P
	US20060773300P	13.02.2006 Original published format: US 773300 P
	[2008/13]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2006125132
	Date:	23.11.2006
	Language:	EN
	[2006/47]
	Type:	A2 Application without search report
	No.:	EP1901749
	Date:	26.03.2008
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 23.11.2006 takes the place of the publication of the European patent application.
	[2008/13]
	Type:	B1 Patent specification
	No.:	EP1901749
	Date:	03.08.2016
	Language:	EN
	[2016/31]
Search report(s)	International search report - published on:	EP	28.12.2006
Classification	IPC:	A61K31/5383, A61K33/14, A61K33/06, A61K9/12, A61K9/08, A61P11/00, A61P31/04	[2016/25]
	CPC:	A61K9/0078 (EP); A61K31/538 (KR,RU); A61K9/12 (KR,RU); A61K31/4375 (KR); A61K31/47 (KR,RU); A61K31/5383 (EP); (+) A61K33/06 (EP); A61K33/14 (EP); A61K9/0075 (EP); A61P11/00 (EP); A61P31/04 (EP); C07D498/06 (RU); A61K9/14 (EP); A61K9/145 (EP); Y02A50/30 (EP) (-)
	C-Set:	A61K31/5383, A61K2300/00 (EP); A61K33/06, A61K2300/00 (EP); A61K33/14, A61K2300/00 (EP)
	Former IPC [2008/13]	A61K31/538, A61K31/4375, A61K31/47, A61K9/12, A61P11/00
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2016/31]
Former [2008/13]	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR
Extension states	AL	06.12.2007
	BA	06.12.2007
	HR	06.12.2007
	MK	06.12.2007
	YU	06.12.2007
Title	German:	AEROSOLISIERTE FLUOROCHINOLONE UND IHRE VERWENDUNGEN	[2008/13]
	English:	AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF	[2008/13]
	French:	FLUOROQUINOLONES EN AEROSOLS ET LEURS UTILISATIONS	[2008/13]
Entry into regional phase	06.12.2007	National basic fee paid
	06.12.2007	Designation fee(s) paid
	06.12.2007	Examination fee paid
Examination procedure	06.12.2007	Amendment by applicant (claims and/or description)
	06.12.2007	Examination requested [2008/13]
	20.10.2010	Despatch of a communication from the examining division (Time limit: M06)
	29.04.2011	Reply to a communication from the examining division
	11.06.2015	Despatch of a communication from the examining division (Time limit: M06)
	18.12.2015	Reply to a communication from the examining division
	18.02.2016	Despatch of a communication from the examining division (Time limit: M04)
	24.03.2016	Reply to a communication from the examining division
	02.06.2016	Communication of intention to grant the patent
	21.06.2016	Fee for grant paid
	21.06.2016	Fee for publishing/printing paid
	21.06.2016	Receipt of the translation of the claim(s)
Divisional application(s)	EP12007354.9 / EP2594272
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 20.10.2010
Opposition(s)	04.05.2017	No opposition filed within time limit [2017/28]
Fees paid	Renewal fee
	11.03.2008	Renewal fee patent year 03
	12.05.2009	Renewal fee patent year 04
	31.03.2010	Renewal fee patent year 05
	11.05.2011	Renewal fee patent year 06
	29.03.2012	Renewal fee patent year 07
	28.05.2013	Renewal fee patent year 08
	27.05.2014	Renewal fee patent year 09
	27.05.2015	Renewal fee patent year 10
	27.05.2016	Renewal fee patent year 11
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]US2001049366 (SINGH ONKAR N [US], et al) [X] 1,2,8-13,25,54 * the whole document * * paragraph [0011]; claims 1-12 * * paragraph [0015] * * paragraph [0020] * * examples 1-4 *;
		[X]WO0218345 (CHIRON CORP [US], et al) [X] 1-100 * the whole document * * page 1, line 15 - page 9, line 33 * * page 14, line 16 - page 15, line 12 * * page 15, line 13 - page 22, line 31 * * example 11 * * example 34; claims 1-11; table 5 *;
		[X]WO02072102 (ORTHO MCNEIL PHARM INC [US]) [X] 1-100 * page 2, line 13 - line 21 * * page 2, line 30 - page 5, line 19 * * page 6, line 11 - line 21 * * page 6, line 31 - page 7, line 6 * * page 8, line 3 - page 9, line 31 * * page 10, line 16 - line 17 * * page 10, line 31 - page 11, line 20 * * page 14, line 3 - line 15 * * page 18, line 1 - line 13 * * page 18, line 27 - page 19, line 6 * * examples 3-17 * * claims 1-84 *;
		[PX]WO2005089738 (MPEX PHARMACEUTICALS INC [US], et al) [PX] 1-100 * paragraph [0435] - paragraph [0441]; example 15 * * claims 20-26,29 *;
		[X] - WEBER A ET AL, "EFFECT OF NEBULIZER TYPE AND ANTIBIOTIC CONCENTRATION ON DEVICE PERFORMANCE", PEDIATRIC PULMONOLOGY, JOHN WILEY, NEW YORK, NY, US, (199704), vol. 23, no. 4, ISSN 8755-6863, pages 249 - 260, XP001118136 [X] 1-100 * the whole document * DOI: http://dx.doi.org/10.1002/(SICI)1099-0496(199704)23:4<249::AID-PPUL2>3.0.CO;2-H
		[X] - HUNG J C. ET AL., "Evaluation of two commercial jet nebulisers and three compressors for the nebulisation of antibiotics", ARCHIVES OF DISEASE IN CHILDHOOD, ENGLAND, (199410), vol. 71, no. 4, pages 335 - 338, XP009073650 [X] 1-100 * the whole document * DOI: http://dx.doi.org/10.1136/adc.71.4.335

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p